PA

Philippe Armand

Mutual Connections
Loading...
S9-052025-1214030

Send Message

No file chosen
2 Publications
0 Followers
0 Following
0 Questions

👤 About

Skills & Expertise

No skills added yet.

Research Interests

No research interests added yet.

Connect With Me

📚 Publications (2)

Journal: Leukemia & Lymphoma • November 2022
The multicohort phase 1b KEYNOTE-013 study (NCT01953692) evaluated the safety and efficacy of pembrolizumab in patients with relapsed or refractory NHL who were ineligible for or failed hematopoietic...
Pd-l1 B-cell lymphoma Pembrolizumab Non-hodgkin lymphoma
Journal: Leukemia & Lymphoma • July 2024
Several vaccine strategies have been tested for the treatment of follicular lymphoma; however, none have proven successful. In a phase I dose-escalation protocol, we developed a vaccine consisting of...
Immunotherapy Gvax Gm-csf Vaccine Follicular lymphoma
dd